Drug Use-Results Survey on Picoprep® Combination Powder

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03631446

Enrollment

1298

Registered

2018-08-15

Start date

2017-08-29

Completion date

2021-12-31

Last updated

2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Cleansing

Brief summary

The purpose of this survey is to confirm safety and efficacy with patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.

Interventions

DRUGSodium Picosulfate, Magnesium Oxide and Citric Acid

Combination powder for oral solution

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.

Design outcomes

Primary

Measure	Time frame	Description
Bowel cleansing assessment for colonoscopy	48 hours after drug administration	Assessment of each part of large intestine using a bowel cleanliness rating scale
Bowel cleansing assessment for colorectal surgery	48 hours after drug administration	Assessment of each part of large intestine using a bowel cleanliness rating scale

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026